Total Payments
$243,220
2024 Payments
$55,730
Companies
9
Transactions
145
Medicare Patients
297
Medicare Billing
$15,517
Payment Breakdown by Category
Consulting$147,337 (60.6%)
Other$64,833 (26.7%)
Travel$23,012 (9.5%)
Research$4,975 (2.0%)
Food & Beverage$2,958 (1.2%)
Education$105.07 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $147,337 | 28 | 60.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,133 | 14 | 21.8% |
| Travel and Lodging | $23,012 | 51 | 9.5% |
| Honoraria | $11,700 | 3 | 4.8% |
| Unspecified | $4,975 | 5 | 2.0% |
| Food and Beverage | $2,958 | 40 | 1.2% |
| Education | $105.07 | 4 | 0.0% |
Payments by Type
General
$238,245
140 transactions
Research
$4,975
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $92,178 | 50 | $0 (2023) |
| PFIZER INC. | $63,900 | 33 | $0 (2024) |
| LEO Pharma AS | $34,125 | 7 | $0 (2020) |
| GENZYME CORPORATION | $31,155 | 16 | $0 (2024) |
| Lilly USA, LLC | $14,261 | 25 | $0 (2024) |
| ABBVIE INC. | $6,713 | 11 | $0 (2024) |
| Allergan Inc. | $833.33 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $30.00 | 1 | $0 (2024) |
| LEO Pharma Inc. | $25.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55,730 | 29 | GENZYME CORPORATION ($31,155) |
| 2023 | $68,674 | 55 | Eli Lilly and Company ($35,311) |
| 2022 | $31,192 | 21 | Eli Lilly and Company ($15,407) |
| 2021 | $22,025 | 6 | PFIZER INC. ($11,100) |
| 2020 | $46,242 | 6 | LEO Pharma AS ($32,336) |
| 2019 | $2,637 | 8 | LEO Pharma AS ($1,789) |
| 2018 | $16,196 | 19 | Eli Lilly and Company ($16,104) |
| 2017 | $525.00 | 1 | Eli Lilly and Company ($525.00) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: Inflammation & Immunology | ||||||
| 11/08/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $11,956.00 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $490.71 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $263.01 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $258.77 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $135.92 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $99.05 | General |
| 11/04/2024 | PFIZER INC. | LITFULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: Immunology | ||||||
| 06/24/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Inflammation & Immunology | ||||||
| 06/12/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,500.00 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $640.40 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $514.42 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $449.87 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $216.12 | General |
| Category: Inflammation & Immunology | ||||||
| 04/19/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $16,226.00 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $796.56 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $289.88 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $166.03 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $142.99 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Food and Beverage | Cash or cash equivalent | $59.85 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $59.11 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $56.90 | General |
| 04/19/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $54.55 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RITLECITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,470 | 3 |
| A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPERATIONALLY SEAMLESS, ADAPTIVE PHASE 2/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH SEVERE OR VERY SEVERE ALOPECIA AREATA | Eli Lilly and Company | $505.04 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 62 | 66 | $10,708 | $3,891 |
| 2022 | 3 | 53 | 65 | $7,328 | $3,764 |
| 2021 | 1 | 15 | 16 | $1,792 | $1,087 |
| 2020 | 5 | 167 | 241 | $30,063 | $6,774 |
Total Patients
297
Total Services
388
Medicare Billing
$15,517
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 19 | $2,204 | $1,510 | 68.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 14 | $1,624 | $1,174 | 72.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 14 | $4,053 | $681.75 | 16.8% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 19 | 19 | $2,827 | $525.17 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 26 | $2,972 | $2,126 | 71.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 20 | $1,544 | $1,056 | 68.4% |
| 99451 | Telephone or internet assessment with written report by consulting physician, 5 minutes or more | Office | 2022 | 19 | 19 | $2,812 | $582.99 | 20.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 16 | $1,792 | $1,087 | 60.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 40 | $7,205 | $2,514 | 34.9% |
| 99451 | Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | Office | 2020 | 72 | 72 | $10,656 | $1,978 | 18.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 38 | $6,542 | $1,526 | 23.3% |
| 17000 | Destruction of skin growth | Office | 2020 | 16 | 18 | $4,724 | $640.09 | 13.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 12 | 73 | $936.00 | $115.31 | 12.3% |
About Dr. Justin Ko, MD
Dr. Justin Ko, MD is a Dermatology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2009. The National Provider Identifier (NPI) number assigned to this provider is 1790912251.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Ko, MD has received a total of $243,220 in payments from pharmaceutical and medical device companies, with $55,730 received in 2024. These payments were reported across 145 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($147,337).
As a Medicare-enrolled provider, Ko has provided services to 297 Medicare beneficiaries, totaling 388 services with total Medicare billing of $15,517. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Stanford, CA
- Active Since 06/11/2009
- Last Updated 04/16/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1790912251
Products in Payments
- CIBINQO (Drug) $30,181
- LITFULO (Drug) $8,236
- OLUMIANT (Drug) $6,188
- EUCRISA (Drug) $1,599
- RINVOQ (Biological) $1,180
- TALTZ (Drug) $616.99
- Sotyktu (Drug) $30.00
- Skyrizi (Biological) $14.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Stanford
Matthew Lewis, Md, MD
Dermatology — Payments: $303,775
Dermatology $303,775
David Fiorentino, Md, MD
Dermatology — Payments: $218,980
Dermatology $218,980
Zakia Rahman, Md, MD
Dermatology — Payments: $171,847
Dermatology $171,847
Anne Lynn Chang, Md, MD
Dermatology — Payments: $148,354
Dermatology $148,354
Youn-Hee Kim, Md, MD
Dermatology — Payments: $87,849
Dermatology $87,849
Matt Marinkovich, Md, MD
Dermatology — Payments: $63,624
Dermatology $63,624